Evidence map›Paper›PMID 36454480›Full record

ArticleCellular and molecular life sciences : CMLS2022

RBM24 controls cardiac QT interval through CaMKIIδ splicing.

Jing Liu, Ke Wang, Xingyang Liu, Lei Pan, Wanlu Zhou, Jingru Huang, Hongli Liu, Zhiying Su, Xiu Qin Xu

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. RNA-Binding Proteins in Cardiomyopathies.Journal of cardiovascular development and disease · 2024
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jing Liu *The Institute of Stem Cell and Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, 361100, Fujian, People's Republic of China.
Ke Wang *The Institute of Stem Cell and Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, 361100, Fujian, People's Republic of China.
Xingyang LiuSchool of Medicine, Xiamen University, Xiamen, 361100, Fujian, People's Republic of China.
Lei PanThe Institute of Stem Cell and Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, 361100, Fujian, People's Republic of China.
Wanlu ZhouThe Institute of Stem Cell and Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, 361100, Fujian, People's Republic of China.
Jingru HuangThe Institute of Stem Cell and Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, 361100, Fujian, People's Republic of China.
Hongli LiuThe Institute of Stem Cell and Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, 361100, Fujian, People's Republic of China.
Zhiying SuThe Institute of Stem Cell and Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, 361100, Fujian, People's Republic of China.
Xiu Qin XuThe Institute of Stem Cell and Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, 361100, Fujian, People's Republic of China. xuxq@xmu.edu.cn.ORCID http://orcid.org/0000-0003-3720-5088
Xiamen University · CNShenzhen University · CN

Funding

Fundamental Research Funds for Central Universities of the Central South University 20720220058National Natural Science Foundation of China 81871744National Natural Science Foundation of China 82070424Natural Science Foundation of Fujian Province 2021J01011Natural Science Foundation of Guangdong Province 2017A030313113the National Key R&D program of China 2018YFA0107304
6 · The paper itself

Abstract

Calcium/calmodulin-dependent kinase II delta (CaMKIIδ) is the predominant cardiac isoform and it is alternatively spliced to generate multiple variants. Variable variants allow for distinct localization and potentially different functions in the heart. Dysregulation of CaMKIIδ splicing has been demonstrated to be involved in the pathogenesis of heart diseases, such as cardiac hypertrophy, arrhythmia, and diastolic dysfunction. However, the mechanisms that regulate CaMKIIδ are incompletely understood. Here, we show that RNA binding motif protein 24 (RBM24) is a key splicing regulator of CaMKIIδ. RBM24 ablation leads to the aberrant shift of CaMKIIδ towards the δ-C isoform, which is known to activate the L-type Ca current. In line with this, we found marked alteration in Ca

Indexed as

Heart DiseasesRNA SplicingAction PotentialsAnimalsHeart VentriclesHumansMiceMice, KnockoutMyocytes, CardiacRNA-Binding ProteinsRBM24 protein, humanRbm24 protein, mouseRNA-Binding ProteinsAlternative splicingArrhythmiaCalciumCalmodulin-dependent protein kinase II δRNA binding motif 24

Identifiers

PMID36454480
PMCPMC11802997
OpenAlexW4311060014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.